BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hwang YJ, Kim N, Lee HS, Lee JB, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther. 2018;47:380-390. [PMID: 29193217 DOI: 10.1111/apt.14424] [Cited by in Crossref: 74] [Cited by in F6Publishing: 54] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Yoon K, Kim N. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of Helicobacter pylori. Korean J Gastroenterol 2018;72:104. [DOI: 10.4166/kjg.2018.72.3.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kuo HY, Chang WL, Yeh YC, Cheng HC, Tsai YC, Wu CT, Lin SH, Yang HB, Lu CC, Sheu BS. Spasmolytic polypeptide-expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives. Helicobacter 2019;24:e12578. [PMID: 30990573 DOI: 10.1111/hel.12578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Okada K, Suzuki S, Naito S, Yamada Y, Haruki S, Kubota M, Nakajima Y, Shimizu T, Ando K, Uchida Y, Hirasawa T, Fujisaki J, Tsuchida T. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication. Gastrointest Endosc. 2019;89:1152-1159.e1. [PMID: 30825537 DOI: 10.1016/j.gie.2019.02.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
4 Hojati SA, Kokabpeyk S, Yaghoubi S, Joukar F, Asgharnezhad M, Mansour-Ghanaei F. Helicobacter pylori infection in Iran: demographic, endoscopic and pathological factors. BMC Gastroenterol 2021;21:355. [PMID: 34579657 DOI: 10.1186/s12876-021-01931-1] [Reference Citation Analysis]
5 Yang H, Zhou X, Hu B. The "reversibility" of chronic atrophic gastritis after the eradication of Helicobacter pylori. Postgrad Med 2022. [PMID: 35382697 DOI: 10.1080/00325481.2022.2063604] [Reference Citation Analysis]
6 Lee S. Serum Assay Findings after Successful Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res 2021;21:287-99. [DOI: 10.7704/kjhugr.2021.0031] [Reference Citation Analysis]
7 Lee S. Helicobacter pylori-negative Gastric Cancer. Korean J Helicobacter Up Gastrointest Res 2021;21:10-21. [DOI: 10.7704/kjhugr.2020.0036] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Watari J, Ito C, Shimoda T, Tomita T, Oshima T, Fukui H, Das KM, Miwa H. DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin use. Sci Rep 2019;9:12559. [PMID: 31467363 DOI: 10.1038/s41598-019-49069-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Huang RJ, Hwang JH. Improving the Early Diagnosis of Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:503-17. [PMID: 34053636 DOI: 10.1016/j.giec.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hwang Y, Kim N, Kim SE, Baik GH, Lee JY, Park KS, Joo Y, Myung D, Kim HJ, Song HJ, Kim HU, Nam K, Shin JE, Kim HJ, Kim GH, Lee J, Lim SH, Seo GS, Choi SC. Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials. Korean J Helicobacter Up Gastrointest Res 2018;18:247. [DOI: 10.7704/kjhugr.2018.18.4.247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kim HJ, Kim N, Park JH, Choi S, Shin CM, Lee OJ. Helicobacter pylori Eradication Induced Constant Decrease in Interleukin- 1B Expression over More Than 5 Years in Patients with Gastric Cancer and Dysplasia. Gut Liver 2020;14:735-45. [PMID: 32703913 DOI: 10.5009/gnl19312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen M, Fang Y, Cheng L, Wu H. Helicobacter pylori is associated with poor prognosis of laryngeal precancerous lesion. Auris Nasus Larynx 2020;47:268-75. [PMID: 31443928 DOI: 10.1016/j.anl.2019.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Jiang J, Shen S, Dong N, Liu J, Xu Q, Sun L, Yuan Y. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases. Cancer Med 2018;7:4068-76. [PMID: 29963765 DOI: 10.1002/cam4.1615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Zhang Y, Li F, Yuan F, Zhang K, Huo L, Dong Z, Lang Y, Zhang Y, Wang M, Gao Z, Qin Z, Shen L. Diagnosing chronic atrophic gastritis by gastroscopy using artificial intelligence. Dig Liver Dis. 2020;52:566-572. [PMID: 32061504 DOI: 10.1016/j.dld.2019.12.146] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
15 Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflamm Res 2021;70:1015-26. [PMID: 34549319 DOI: 10.1007/s00011-021-01501-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhang S, Shi D, Li M, Li Y, Wang X, Li W. The relationship between gastric microbiota and gastric disease. Scand J Gastroenterol 2019;54:391-6. [PMID: 30945954 DOI: 10.1080/00365521.2019.1591499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
17 Lee S. Helicobacter pylori Infection and the Kyoto Classification of Gastritis. Korean J Helicobacter Up Gastrointest Res 2019;19:81-7. [DOI: 10.7704/kjhugr.2019.19.2.81] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
18 Hwang Y, Kim N, Yun CY, Kwon MG, Baek SM, Kwon YJ, Lee HS, Lee JB, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH. Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia: A Long-term Prospective Clinical Study. Korean J Helicobacter Up Gastrointest Res 2018;18:186. [DOI: 10.7704/kjhugr.2018.18.3.186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
19 Sánchez Delgado J, García-iglesias P, Titó L, Puig I, Planella M, Gené E, Saló J, Martínez-cerezo F, Molina-infante J, Gisbert JP, Calvet X. Actualización en el manejo de la infección por Helicobacter pylori. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2018;41:272-80. [DOI: 10.1016/j.gastrohep.2017.12.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
20 Tang CT, Zeng L, Yang J, Zeng C, Chen Y. Analysis of the Incidence and Survival of Gastric Cancer Based on the Lauren Classification: A Large Population-Based Study Using SEER. Front Oncol 2020;10:1212. [PMID: 32850357 DOI: 10.3389/fonc.2020.01212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kim HJ, Kim N, Yun CY, Lee HS. The clinical meaning of the "indefinite for atrophy" lesions within gastric mucosa biopsy specimens in a region with a high prevalence of gastric cancer. Helicobacter 2019;24:e12605. [PMID: 31304663 DOI: 10.1111/hel.12605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yi Y, Hu Z, Li R, Chen L, Zhang H, Li H, Wu M, Liu W. Effectiveness of Banxia Xiexin Decoction in the treatment of precancerous lesions: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25607. [PMID: 33879728 DOI: 10.1097/MD.0000000000025607] [Reference Citation Analysis]
23 Rugge M, Savarino E, Sbaraglia M, Bricca L, Malfartheiner P. Gastritis: The clinico-pathological spectrum. Dig Liver Dis 2021:S1590-8658(21)00100-6. [PMID: 33785282 DOI: 10.1016/j.dld.2021.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Cho JH, Jeon SR, Jin SY. Clinical applicability of gastroscopy with narrow-band imaging for the diagnosis of Helicobacter pylori gastritis, precancerous gastric lesion, and neoplasia. World J Clin Cases 2020; 8(14): 2902-2916 [PMID: 32775373 DOI: 10.12998/wjcc.v8.i14.2902] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yun CY, Kim N, Lee J, Lee JY, Hwang YJ, Lee HS, Yoon H, Shin CM, Park YS, Kim JW, Lee DH. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors. Helicobacter. 2018;23:e12542. [PMID: 30303591 DOI: 10.1111/hel.12542] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
26 Jonaitis P, Kupcinskas L, Kupcinskas J. Molecular Alterations in Gastric Intestinal Metaplasia. Int J Mol Sci 2021;22:5758. [PMID: 34071181 DOI: 10.3390/ijms22115758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Fukuda K, Kodama M, Mizukami K, Okamoto K, Ogawa R, Hirashita Y, Fukuda M, Togo K, Matsunari O, Okimoto T, Murakami K. Analysis of long-term serological and histological changes after eradication of <i>Helicobacter pylori</i>. J Clin Biochem Nutr . [DOI: 10.3164/jcbn.21-164] [Reference Citation Analysis]
28 Mommersteeg MC, Nieuwenburg SAV, den Hollander WJ, Holster L, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Burger JPW, Doukas M, Bruno MJ, Peppelenbosch MP, Fuhler GM, Kuipers EJ, Spaander MCW. Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance. Gastric Cancer 2021;24:680-90. [PMID: 33616776 DOI: 10.1007/s10120-020-01149-2] [Reference Citation Analysis]
29 Waldum HL, Rehfeld JF. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia. Scand J Gastroenterol 2019;54:1118-23. [PMID: 31524029 DOI: 10.1080/00365521.2019.1663446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
30 Choi JM, Kim SG. Effect of Helicobacter pylori Eradication on Epigenetic Changes in Gastric Cancer-related Genes. Korean J Helicobacter Up Gastrointest Res 2021;21:256-66. [DOI: 10.7704/kjhugr.2021.0042] [Reference Citation Analysis]
31 Zhou JJ, Shi X, Zheng SP, Tang D, Cai T, Yao Y, Wang F. Efficacy of bismuth-based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large-scale prospective, single-center clinical trial in China. Helicobacter 2020;25:e12755. [PMID: 32914914 DOI: 10.1111/hel.12755] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Choi Y, Kim N, Yun CY, Choi YJ, Yoon H, Shin CM, Park YS, Ahn SH, Joong Park D, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Lee DH, Kim HH. Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years. Gastric Cancer 2020;23:1051-63. [PMID: 32361784 DOI: 10.1007/s10120-020-01076-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Noh G, Kim N, Choi Y, Lee HS, Hwang YJ, Kim HJ, Yoon H, Shin CM, Park YS, Lee DH. Long-term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication. J Gastroenterol Hepatol 2020;35:1540-8. [PMID: 32090375 DOI: 10.1111/jgh.15017] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Lahner E, Carabotti M, Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J Gastroenterol 2018; 24(22): 2373-2380 [PMID: 29904244 DOI: 10.3748/wjg.v24.i22.2373] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
35 Uno Y. Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan. Cancer Med 2019;8:3992-4000. [PMID: 31119891 DOI: 10.1002/cam4.2277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
36 Lazăr DC, Avram MF, Faur AC, Romoşan I, Goldiş A. The role of computer-assisted systems for upper-endoscopy quality monitoring and assessment of gastric lesions. Gastroenterol Rep (Oxf) 2021;9:185-204. [PMID: 34316369 DOI: 10.1093/gastro/goab008] [Reference Citation Analysis]
37 Liu W, Tian J, Hui W, Kong W, Feng Y, Si J, Gao F. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis. Sci Rep 2021;11:4143. [PMID: 33603125 DOI: 10.1038/s41598-021-83647-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial. Gastrointest Endosc. 2018;88:475-485.e2. [PMID: 29800546 DOI: 10.1016/j.gie.2018.05.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 10.5] [Reference Citation Analysis]
39 Lahner E, Conti L, Annibale B, Corleto VD. Current Perspectives in Atrophic Gastritis. Curr Gastroenterol Rep 2020;22:38. [PMID: 32542467 DOI: 10.1007/s11894-020-00775-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kodama M, Okimoto T, Mizukami K, Hirashita Y, Wada Y, Fukuda M, Matsunari O, Okamoto K, Ogawa R, Fukuda K, Kudo Y, Kawahara Y, Murakami K. Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study. J Gastroenterol Hepatol 2021;36:2210-6. [PMID: 33656793 DOI: 10.1111/jgh.15477] [Reference Citation Analysis]
41 Ansari S, Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clin Microbiol Rev 2022;:e0025821. [PMID: 35404105 DOI: 10.1128/cmr.00258-21] [Reference Citation Analysis]
42 Garg A, Rodriguez A, Lewis JT, Bansal R, Brahmbhatt B. Energy Drinks: A Reversible Risk Factor for Atrophic Gastritis and Gastric Intestinal Metaplasia. Cureus 2020;12:e12298. [PMID: 33520500 DOI: 10.7759/cureus.12298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Yoon K, Kim N. Significance of Helicobacter pylori Eradication on Atrophic Gastritis and Intestinal Metaplasia. Korean J Helicobacter Up Gastrointest Res 2020;20:107-16. [DOI: 10.7704/kjhugr.2020.0018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chapelle N, Péron M, Quénéhervé L, Bourget A, Leroy M, Touchefeu Y, Cauchin E, Coron E, Mosnier JF, Matysiak-Budnik T. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Clin Transl Gastroenterol 2020;11:e00237. [PMID: 33512802 DOI: 10.14309/ctg.0000000000000237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wu SR, Liu J, Zhang LF, Wang N, Zhang LY, Wu Q, Liu JY, Shi YQ. Lamb’s tripe extract and vitamin B12 capsule plus celecoxib reverses intestinal metaplasia and atrophy: A retrospective cohort study. World J Clin Cases 2021; 9(34): 10472-10483 [PMID: 35004979 DOI: 10.12998/wjcc.v9.i34.10472] [Reference Citation Analysis]
46 Genta RM. Editorial: the post- Helicobacte r stomach-not the same for cohorts and individuals. Aliment Pharmacol Ther 2018;47:846-7. [DOI: 10.1111/apt.14491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Aumpan N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, Issariyakulkarn N, Ratana-Amornpin S, Miftahussurur M, Mahachai V, Yamaoka Y. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One 2021;16:e0255601. [PMID: 34379655 DOI: 10.1371/journal.pone.0255601] [Reference Citation Analysis]
48 Wang S, Wang Q, Xu L, Yu P, Li Q, Li X, Guo M, Lian B, Ji G. Beware Pathological Findings of the Stomach in Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis. Obes Surg 2021;31:337-42. [PMID: 33047288 DOI: 10.1007/s11695-020-05029-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Niikura R, Hayakawa Y, Hirata Y, Ogura K, Fujishiro M, Yamada A, Ushiku T, Konishi M, Fukayama M, Koike K. The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion. Int J Mol Sci 2019;20:E1913. [PMID: 31003453 DOI: 10.3390/ijms20081913] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
50 Kwon YJ, Kim N, Baek SM, Lee HS, Lee J, Hwang YJ, Yoon H, Shin CM, Park YS, Kim J, Lee DH. The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population. Helicobacter 2019;24:e12579. [DOI: 10.1111/hel.12579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ni BY, Bao LW, Huang QJ, Wu BL, Li W. Relationship of delta over baseline with serum levels of gastrin 17, interleukin-32, and soluble interleukin 2 receptor and gastroscopic pathological changes in patients with chronic atrophic gastritis and Helicobacter pylori infection. Shijie Huaren Xiaohua Zazhi 2021; 29(14): 816-824 [DOI: 10.11569/wcjd.v29.i14.816] [Reference Citation Analysis]
52 Wu SR, Liu YH, Shi YQ. Is intestinal metaplasia the point of no return in the progression of gastric carcinogenesis? Chin Med J (Engl) 2021;134:2965-7. [PMID: 34874672 DOI: 10.1097/CM9.0000000000001889] [Reference Citation Analysis]
53 Ansari S, Yamaoka Y. Current understanding and management of Helicobacter pylori infection: an updated appraisal. F1000Res. 2018;7. [PMID: 29946428 DOI: 10.12688/f1000research.14149.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
54 Wang L, Wang J, Li S, Bai F, Xie H, Shan H, Liu Z, Ma T, Tang X, Tang H, Qin A, Lei S, Zuo C. The effect of Helicobacter pylori eradication on prognosis of postoperative early gastric cancer: a multicenter study. World J Surg Oncol 2021;19:285. [PMID: 34548086 DOI: 10.1186/s12957-021-02343-x] [Reference Citation Analysis]
55 Zhang H, Wu S, Feng J, Liu Z. Risk Factors of Prolonged Nausea and Vomiting During Pregnancy. Risk Manag Healthc Policy 2020;13:2645-54. [PMID: 33239926 DOI: 10.2147/RMHP.S273791] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Watari J, Tomita T, Tozawa K, Oshima T, Fukui H, Miwa H. Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin. Gut Liver 2020;14:281-90. [PMID: 31547640 DOI: 10.5009/gnl19079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Companioni O, Bonet C, García N, Ramírez-lázaro MJ, Lario S, Mendoza J, Adrados MM, Poves E, Espinosa L, Pozo-kreilinger JJ, Ortega L, Bujanda L, Cosme A, Ferrández A, Muñoz G, Cuatrecasas M, Elizalde I, Andreu V, Paules MJ, Madrigal B, Barrio J, Berdasco M, Calvet X, Sanz-anquela JM, Gisbert JP, González CA, Sala N; on behalf of the Study Group. Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14: Genetic variation and gastric cancer precursor lesions. Int J Cancer 2018;143:2777-86. [DOI: 10.1002/ijc.31839] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
58 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, Falck-Ytter Y, Mustafa RA. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology. 2020;158:693-702. [PMID: 31816298 DOI: 10.1053/j.gastro.2019.12.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 16.7] [Reference Citation Analysis]
60 Nam HS, Kim HW, Choi CW, Kang DH, Park SB, Kim SJ, Choi JS. Characteristics of overlooked synchronous gastric epithelial neoplasia after endoscopic submucosal dissection. Medicine (Baltimore) 2018;97:e12536. [PMID: 30278545 DOI: 10.1097/MD.0000000000012536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
61 Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM Jr, Correa P, Wilson KT. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions. Gastroenterology 2021;160:1106-1117.e3. [PMID: 33220252 DOI: 10.1053/j.gastro.2020.11.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
62 Lahner E, Carabotti M, Esposito G, Hassan C, Zullo A, Annibale B. Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms. European Journal of Gastroenterology & Hepatology 2018;30:1291-6. [DOI: 10.1097/meg.0000000000001246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
63 Fornaro L, Spallanzani A, de Vita F, D'Ugo D, Falcone A, Lorenzon L, Tirino G, Cascinu S; GAIN (GAstric Cancer Italian Network). Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel) 2021;13:1304. [PMID: 33804024 DOI: 10.3390/cancers13061304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Rugge M. Biologic profiles meet clinical priorities: incorporating pseudopyloric, and spasmolytic-expressing metaplasia in the assessment of gastric atrophy. Virchows Arch 2020;477:487-8. [PMID: 32394165 DOI: 10.1007/s00428-020-02814-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Yang H, Yang WJ, Hu B. Gastric epithelial histology and precancerous conditions. World J Gastrointest Oncol 2022; 14(2): 396-412 [DOI: 10.4251/wjgo.v14.i2.396] [Reference Citation Analysis]
66 Carabotti M, Annibale B, Lahner E. Common Pitfalls in the Management of Patients with Micronutrient Deficiency: Keep in Mind the Stomach. Nutrients 2021;13:208. [PMID: 33450823 DOI: 10.3390/nu13010208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Weng CY, Xu JL, Sun SP, Wang KJ, Lv B. Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa. World J Gastroenterol 2021; 27(31): 5152-5170 [PMID: 34497441 DOI: 10.3748/wjg.v27.i31.5152] [Reference Citation Analysis]
68 Gómez A, Pato ML, Bujanda L, Sala N, Companioni O, Cosme Á, Tufano M, Hanly DJ, García N, Sanz-Anquela JM, Gisbert JP, López C, Elizalde JI, Cuatrecasas M, Andreu V, Paules MJ, Martín-Arranz MD, Ortega L, Poves E, Barrio J, Torres MÁ, Muñoz G, Ferrández Á, Ramírez-Lázaro MJ, Lario S, González CA, Esteller M, Berdasco M. Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions. Cancers (Basel) 2021;13:2760. [PMID: 34199386 DOI: 10.3390/cancers13112760] [Reference Citation Analysis]
69 Kim N. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism. J Gastroenterol Hepatol 2019;34:1287-95. [PMID: 30828872 DOI: 10.1111/jgh.14646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]